Know Cancer

or
forgot password

Retrospective Study of Molecular Predictors of Sensitivity and Resistance to Pemetrexed in Advanced Non-Small Cell Lung Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Non-small Cell Lung Cancer (NSCLC)

Thank you

Trial Information

Retrospective Study of Molecular Predictors of Sensitivity and Resistance to Pemetrexed in Advanced Non-Small Cell Lung Cancer


Inclusion Criteria:



- Histologically confirmed diagnosis of advanced non-small cell lung cancer - Tumor
tissue available at our institution

- Patients treated with single agent pemetrexed for metastatic disease

- Availability of full clinical data

Exclusion Criteria:

- Cytological diagnosis of advanced Non-small cell lung cancer

- Lack of tumor tissue at our institution

- Lack of full clinical data

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Association of each biomarker with treatment outcome in terms of response rate, time to progression, overall survival.

Outcome Time Frame:

one year

Safety Issue:

No

Principal Investigator

Armando SANTORO, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Istituto Clinico Humanitas

Authority:

Italy: Ministry of Health

Study ID:

ONC/OSS-02/2010

NCT ID:

NCT01193959

Start Date:

September 2010

Completion Date:

September 2011

Related Keywords:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location